Design (Testphase)
Momentum & Trend
Richard Moglen: 1 Week Top Performers
28
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 25 strongest hits
Moglen's weekly watchlist (TraderLion): the strongest liquid stocks of the past trading week — at least +15% over the last 4 trading days, average dollar volume ≥ $10M, and RS rating ≥ 70. Thresholds calibrated by Minnow Street (Moglen's original values aren't public); the purpose is the same: whatever leads the pack this week belongs on next week's watchlist.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Liquidity
- How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MXL MaxLinear Inc | 07/22 | +69 % | 72 7/25 | Stage 2 | B +17 | 4 of 9 | 8.5 | Semiconductors | Sells AI | — | Technology | 75.00 $ | +411.1 % | +518.4 % | +549.3 % | −11.1 % | -27.6 % | 99 | 8 | 10.9 % | 11.9 % | 3.93 | — | 70.4 | 16.6 | 16.8 | 837.9 | 0.39 | 92.8 | -12.2 % | 57.2 % | -26.0 % | -27.9 % | -6.2 % | 0.33 | 58.9 % | +29.7 % | 0.0 % | 0.0 % | 2.4 | 87.4 % | 4.8 % | 1.4 (11) | |
| ERAS Erasca Inc | 08/11 | +154 % | 88 8/22 | Stage 2 | E -52 | 2 of 9 | 4.8 | Biotechnology | – | — | — | Healthcare | 18.80 $ | +305.1 % | +433.2 % | +982.7 % | −38.4 % | +40.5 % | 99 | 42 | 8.6 % | 8.3 % | 0.67 | — | 0.0 | — | 11.9 | — | — | -1.6 | 0.0 % | — | 0.0 % | -69.9 % | -17.9 % | 0.12 | 85.3 % | — | 0.0 % | 0.0 % | 1.0 | 93.3 % | 11.4 % | 1.0 (8) |
| UCTT Ultra Clean Holdings Inc | 07/27 | +70 % | 92 10/25 | Stage 2 | C -10 | 2 of 9 | 6.0 | Semiconductor Equipment & Ma | – | — | — | Technology | 91.80 $ | +340.7 % | +399.2 % | +444.0 % | −3.5 % | -11.0 % | 98 | 17 | 8.9 % | 8.7 % | 1.83 | — | 44.4 | 2.9 | 8.5 | — | 1.27 | 356.2 | 2.1 % | 15.6 % | -9.4 % | -22.5 % | 1.4 % | 1.52 | 33.9 % | -2.1 % | 0.0 % | 0.0 % | 6.3 | 102.9 % | 10.5 % | 1.0 (4) |
| DFTX Definium Therapeutics, Inc. | 07/30 | +332 % | — | Stage 2 | D -49 | 1 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 42.80 $ | +170.2 % | +246.6 % | +534.0 % | −4.7 % | +24.7 % | 98 | 50 | 14.0 % | 8.8 % | 2.21 | — | 0.0 | — | 21.3 | — | — | 0.0 | 0.0 % | — | 0.0 % | -94.7 % | -35.7 % | — | 69.5 % | — | 0.0 % | 0.0 % | 1.4 | 65.6 % | 9.8 % | — |
| BAND Bandwidth Inc | 08/04 | +106 % | 87 9/25 | Stage 2 | C -1 | 7 of 9 | 1.7 | Software - Infrastructure | – | — | — | Technology | 68.80 $ | +241.3 % | +304.3 % | +271.8 % | −31.1 % | +6.6 % | 98 | 42 | 8.6 % | 8.7 % | 2.92 | — | 23.0 | 2.1 | 4.1 | 21.8 | — | 53.1 | -2.2 % | 38.2 % | -0.6 % | -1.4 % | -0.9 % | 1.04 | 41.2 % | +0.7 % | 0.0 % | 0.0 % | 3.6 | 80.1 % | 5.2 % | 1.7 (6) |
| SLS Sellas Life Sciences Group Inc | 08/11 | +148 % | — | Stage 2 | C +5 | 3 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 12.50 $ | +140.6 % | +444.0 % | +436.3 % | −4.8 % | -5.0 % | 98 | 50 | 12.4 % | 11.1 % | 2.43 | — | 0.0 | — | — | — | — | -1.7 | 0.0 % | — | 0.0 % | -43.6 % | -25.5 % | — | 94.1 % | -100.0 % | 0.0 % | 0.0 % | 16.0 | 27.6 % | 32.4 % | 1.0 (3) |
| ACMR Acm Research Inc | 08/05 | +247 % | 73 7/25 | Stage 2 | B +15 | 3 of 9 | 7.3 | Semiconductor Equipment & Ma | Neutral | — | Technology | 82.50 $ | +151.3 % | +196.5 % | +311.7 % | −4.1 % | -4.4 % | 97 | 24 | 10.7 % | 10.4 % | 1.90 | 78.1 | 60.6 | 7.6 | 4.7 | — | — | 35.5 | 15.6 % | 44.2 % | 9.5 % | 7.6 % | 3.0 % | 0.21 | 51.6 % | +15.2 % | 0.0 % | 0.0 % | 9.7 | 74.2 % | 4.4 % | 1.1 (9) | |
| MBX MBX Biosciences, Inc. Common Stock | 08/06 | — | 69 6/22 | Stage 2 | D -33 | 3 of 9 | 2.3 | Biotechnology | – | — | — | Healthcare | 60.10 $ | +47.1 % | +67.7 % | +397.4 % | −4.1 % | +37.2 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 5.5 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | 0.0 % | 0.0 % | 37.2 | 111.5 % | 16.8 % | 1.0 (5) |
| ATEX Anterix Inc | 08/11 | +51 % | 89 9/24 | Stage 2 | A +55 | 7 of 9 | 1.5 | Telecom Services | Neutral | — | Communication Services | 101.90 $ | +266.4 % | +339.9 % | +179.1 % | −8.1 % | -1.2 % | 97 | 85 | 8.3 % | 8.2 % | 0.83 | 18.6 | 0.0 | 231.7 | 6.7 | 278.0 | — | -12.4 | — | 100.0 % | 1,394.2 % | 43.3 % | -6.5 % | 0.02 | — | +7.8 % | 0.0 % | 0.0 % | 3.5 | 91.8 % | 14.9 % | — | |
| FCEL FuelCell Energy Inc | — | -22 % | 85 10/29 | Stage 2 | C -9 | 4 of 9 | 1.5 | Electrical Equipment & Parts | Neutral | — | Industrials | 19.80 $ | +198.5 % | +239.8 % | +266.7 % | −29.0 % | +12.0 % | 97 | 42 | 20.4 % | 18.0 % | 2.31 | — | 17.1 | 8.9 | 1.9 | — | 0.36 | 3,082.7 | — | -18.2 % | -132.4 % | -30.7 % | -7.7 % | 0.22 | — | +41.1 % | 0.0 % | 0.0 % | 1.4 | 38.6 % | 10.2 % | — | |
| VSAT ViaSat Inc | 08/04 | +22 % | 60 6/25 | Stage 2 | C +5 | 8 of 9 | 8.2 | Communication Equipment | – | — | — | Technology | 69.50 $ | +85.4 % | +118.2 % | +385.0 % | −33.2 % | +57.6 % | 96 | 73 | 9.0 % | 9.1 % | 1.70 | — | 144.9 | 1.8 | 1.8 | 13.7 | 0.26 | 9.1 | -1.8 % | 33.0 % | -0.7 % | 0.1 % | 0.4 % | 2.29 | 30.6 % | +2.7 % | 0.0 % | 0.0 % | 4.6 | 98.3 % | 10.5 % | 1.2 (9) |
| TWST Twist Bioscience Corp | 08/03 | +131 % | 54 5/22 | Stage 2 | D -16 | 4 of 9 | 6.0 | Diagnostics & Research | – | — | — | Healthcare | 87.50 $ | +168.0 % | +192.9 % | +158.6 % | −1.8 % | -23.3 % | 96 | 42 | 7.7 % | 7.8 % | 2.12 | — | 0.0 | 14.7 | 13.7 | — | — | -35.3 | -34.9 % | 52.1 % | -19.9 % | -18.2 % | -12.9 % | 0.21 | 67.3 % | +20.3 % | 0.0 % | 0.0 % | -0.1 | 123.8 % | 36.4 % | 1.3 (12) |
| GLUE Monte Rosa Therapeutics Inc | 08/06 | +19 % | — | Stage 2 | D -30 | 4 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 23.50 $ | +32.1 % | +35.5 % | +349.4 % | −16.0 % | +53.1 % | 96 | 50 | 8.1 % | 6.8 % | 1.56 | — | 10.9 | — | 3.4 | — | — | 51.9 | — | -238.5 % | 0.0 % | -32.6 % | -16.4 % | 0.08 | — | +63.5 % | 0.0 % | 0.0 % | 7.7 | 113.2 % | 20.7 % | — |
| BLZE Backblaze Inc | 08/06 | +57 % | 62 6/25 | Stage 3 | B +16 | 5 of 9 | 0.8 | Software - Infrastructure | Uses AI | — | Technology | 13.20 $ | +150.2 % | +211.9 % | +134.3 % | −8.2 % | +2.1 % | 96 | 42 | 14.6 % | 9.7 % | 1.55 | — | 178.6 | 5.1 | — | 55.9 | — | 149.5 | — | 62.3 % | -15.0 % | -27.6 % | -5.2 % | — | — | +14.3 % | 0.0 % | 0.0 % | -0.3 | 48.9 % | 2.6 % | — | |
| TXG 10X Genomics Inc | 08/06 | -14 % | 39 4/22 | Stage 2 | C +5 | 6 of 9 | 4.7 | Health Information Services | Uses AI | — | Healthcare | 43.20 $ | +95.4 % | +122.6 % | +220.7 % | −3.1 % | -18.0 % | 95 | 42 | 8.2 % | 7.9 % | 2.04 | — | 666.7 | 7.3 | 5.7 | 38.4 | — | 119.9 | -11.3 % | 69.7 % | -3.6 % | -3.0 % | -4.5 % | 0.10 | 80.2 % | +5.3 % | 0.0 % | 0.0 % | 6.5 | 113.8 % | 25.9 % | 1.6 (16) | |
| APPS Digital Turbine Inc | 08/04 | -13 % | 92 10/25 | Stage 2 | B +29 | 6 of 9 | 1.3 | Software - Application | – | — | — | Technology | 8.30 $ | +85.2 % | +140.0 % | +97.7 % | −5.9 % | -13.9 % | 95 | 17 | 10.7 % | 12.7 % | 2.77 | — | 3.7 | 2.2 | — | 110.7 | 0.69 | 17.7 | — | 48.6 % | -6.7 % | -21.8 % | 2.6 % | — | — | +15.2 % | 0.0 % | 0.0 % | 0.9 | 66.7 % | 10.2 % | — |
| IRDM Iridium Communications Inc | 07/23 | -8 % | 84 8/24 | Stage 2 | C -6 | 6 of 9 | 4.4 | Telecom Services | Neutral | — | — | Communication Services | 46.40 $ | +156.4 % | +216.6 % | +48.6 % | −22.3 % | +7.6 % | 94 | 21 | 9.0 % | 8.0 % | 0.88 | 44.0 | 41.3 | 5.1 | 9.8 | 14.5 | 2.58 | 16.8 | 23.2 % | 71.6 % | 12.0 % | 21.4 % | 5.5 % | 4.77 | 18.5 % | +4.9 % | 1.1 % | 58.8 % | 4.1 | 90.1 % | 10.5 % | 1.1 (9) |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C +1 | 3 of 9 | 8.0 | Biotechnology | Uses AI | — | — | Healthcare | 7.50 $ | +269.7 % | +309.8 % | +182.6 % | −37.3 % | +66.9 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 57.1 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.8 % | 1.0 (5) |
| MEI Methode Electronics Inc | — | -18 % | 62 6/25 | Stage 2 | D -31 | 3 of 9 | 0.7 | Electronic Components | – | — | — | Technology | 15.10 $ | +104.6 % | +185.0 % | +52.0 % | −2.3 % | +7.4 % | 94 | 2 | 13.1 % | 9.7 % | 1.47 | — | 13.7 | 0.7 | 1.0 | 15.4 | 0.78 | 12.1 | — | 19.9 % | -3.5 % | -9.3 % | 0.7 % | 0.52 | — | -2.8 % | 1.3 % | 36.4 % | 7.2 | 93.1 % | 5.0 % | — |
| OUST Ouster, Inc. Common Stock | 08/06 | +244 % | 61 6/25 | Stage 2 | B +16 | 6 of 9 | 2.8 | Electronic Components | Sells AI | — | — | Technology | 34.80 $ | +108.7 % | +141.8 % | +71.8 % | −18.8 % | +12.0 % | 93 | 42 | 15.3 % | 13.5 % | 3.18 | — | 0.0 | 15.2 | — | — | — | -0.8 | -39.6 % | 47.7 % | -30.1 % | -25.2 % | -14.7 % | — | 72.2 % | +52.5 % | 0.0 % | 0.0 % | -0.7 | 50.0 % | 8.4 % | 1.3 (6) |
| GH Guardant Health Inc | 07/29 | +89 % | 78 7/22 | Stage 2 | B +21 | 6 of 9 | 19.0 | Diagnostics & Research | – | — | — | Healthcare | 148.10 $ | +28.1 % | +50.2 % | +182.1 % | −2.0 % | +3.9 % | 92 | 42 | 5.3 % | 5.7 % | 1.59 | — | 0.0 | 17.5 | 55.7 | — | — | -5.4 | -40.2 % | 64.9 % | -40.1 % | -4,584.5 % | -17.2 % | -6.60 | -9.5 % | +32.9 % | 0.0 % | 0.0 % | 0.1 | 106.0 % | 10.3 % | 1.1 (23) |
| ALGM Allegro Microsystems Inc | 07/30 | +12 % | 72 7/25 | Stage 2 | C +4 | 5 of 9 | 12.4 | Semiconductors | – | — | — | Technology | 46.40 $ | +110.5 % | +146.3 % | +73.8 % | −2.5 % | -5.4 % | 92 | 15 | 9.2 % | 8.1 % | 1.90 | — | 58.5 | 14.0 | 10.8 | 99.5 | — | 140.0 | 10.4 % | 46.5 % | -1.7 % | -1.6 % | 1.7 % | 0.30 | 67.5 % | +22.8 % | 0.0 % | 0.0 % | 7.0 | 76.2 % | 13.7 % | 1.1 (11) |
| MNPR Monopar Therapeutics Inc | 08/11 | -10 % | 89 8/22 | Stage 3 | D -38 | 4 of 9 | 0.5 | Biotechnology | – | — | — | Healthcare | 105.90 $ | +25.2 % | +33.6 % | +179.6 % | −16.5 % | +29.7 % | 87 | 42 | 8.6 % | 7.6 % | 1.48 | — | 0.0 | — | 4.3 | — | — | -2.4 | — | — | 0.0 % | -15.9 % | -12.1 % | 0.00 | — | -100.0 % | 0.0 % | 0.0 % | 62.2 | 93.3 % | 34.1 % | — |
| DAVE Dave Inc | 08/05 | +2,117 % | 61 6/25 | Stage 2 | A +69 | 6 of 9 | 4.1 | Software - Application | Uses AI | — | — | Technology | 438.30 $ | +43.6 % | +62.5 % | +50.5 % | −5.8 % | +7.7 % | 83 | 86 | 8.5 % | 8.1 % | 3.83 | — | 23.6 | 6.7 | — | 12.5 | — | 23.0 | 38.3 % | 72.1 % | 37.2 % | 111.6 % | 32.0 % | — | 38.4 % | +59.7 % | 0.0 % | 0.0 % | 11.6 | 100.1 % | 21.7 % | 1.0 (8) |
| CBRL Cracker Barrel Old Country Store | — | -14 % | 74 9/31 | Stage 2 | C +5 | 6 of 9 | 1.1 | Restaurants | – | — | — | Consumer Cyclical | 53.40 $ | +85.7 % | +107.4 % | -17.1 % | −32.8 % | -18.3 % | 81 | 91 | 6.3 % | 6.9 % | 1.19 | 46.0 | 109.9 | 0.3 | 2.5 | 18.1 | 1.56 | 13.9 | — | 31.6 % | 0.8 % | 5.6 % | -0.1 % | 2.35 | — | +0.4 % | 1.9 % | 1.8 % | 3.4 | 97.7 % | 45.0 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Moglen's weekly watchlist (TraderLion): the strongest liquid stocks of the past trading week — at least +15% over the last 4 trading days, average dollar volume ≥ $10M, and RS rating ≥ 70. Thresholds calibrated by Minnow Street (Moglen's original values aren't public); the purpose is the same: whatever leads the pack this week belongs on next week's watchlist.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 28 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- CANSLIM Type RS
- Character Change (CC)
- Chris Perruna: Daily New Highs
- Chris Perruna: Within 15% of Highs
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Cross Fire
- Mike Webster: Down Days Tell Screen
- Mike Webster: Power Trend Leader
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: 52 Week Highs
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Power Trend
- Qullamaggie: Top Gainers 1M
- Qullamaggie: Top Gainers 3M
- Qullamaggie: Top Gainers 6M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: Gaps and Strong Moves
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 1
- Stan Weinstein: Stage 2
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.